NL-OMON44736
Completed
Phase 2
Pilot study: Fosfomycin levels in prostate tissue after oral and iv administration - PROSAB-2
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- prostatitis
- Sponsor
- HagaZiekenhuis
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •a planned transurethral resection of the prostate in patiënts with complaints caused by benign prostatic hyperplasia (BPH)
Exclusion Criteria
- •suspicion of or proven malignancy of the prostate
- •known allergy to fosfomycine
- •renal insufficiency (eGFR \< 40 ml/min)
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
Not yet recruiting
Not Applicable
To check sensitivity of antibiotic towards bacteria causing urinary tract infectioCTRI/2018/08/015475Institutional seeded money
Active, not recruiting
Phase 1
Fosfomycin concentrations in blood in persons with prolonged treatment with fosfomyciEUCTR2018-000616-25-NL15
Completed
Phase 2
Pharmacokinetics of fosfomycin: a study in patients with prolonged treatment for urinary tract infectiobladder infectionUrinary tract infection1000401810046590NL-OMON46751HagaZiekenhuis12
Recruiting
Phase 3
Evaluation of the Effect of Oral fosfomycin Addition on Treatment of Patients with Klebsiella pneumoniae Carbapnemase Infections with ColistiIRCT20191104045328N1Arak University of Medical Sciences62